Physician profile
Stephen A Champlin
NPI 1255383147
$3,662.13
in general payments reported to CMS, 2019-2025
34 companies · $385 in 2025
The $385 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $159 · 2020: $331 · 2021: $572 · 2022: $965 · 2023: $654 · 2024: $597 · 2025: $385.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,622 · Education: $13.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,622.46 |
| Education | $13.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $646.33 | 2019-2024 | Lo Loestrin Fe, Orilissa, Liletta |
| Sumitomo Pharma America, INC. | $367.37 | 2023-2025 | Myfembree, Gemtesa |
| Pfizer INC. | $329.74 | 2019-2025 | |
| Mayne Pharma Commercial LLC | $296.10 | 2021-2025 | |
| Mylan Pharmaceuticals INC. | $228.81 | 2020-2022 | |
| Exeltis, USA INC. | $167.22 | 2021-2025 | Slynd |
| Hologic Sales and Service, LLC | $131.85 | 2020-2025 | Aptima |
| Bayer Healthcare Pharmaceuticals INC. | $126.74 | 2020-2024 | |
| Avion Pharmaceuticals | $108.47 | 2020-2023 | Balcoltra |
| Organon LLC | $106.64 | 2021-2025 | Jada System, Nexplanon |
| Millicent US INC | $100.85 | 2019-2025 | Femring, Intrarosa |
| Intuitive Surgical, INC. | $100.00 | 2023 | Da Vinci Surgical System |
| Biom'Up France Sas | $93.61 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $92.78 | 2020-2022 | |
| Astellas Pharma US INC | $83.21 | 2023-2025 | Veozah, Myrbetriq |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $74.92 | 2021-2022 | |
| Aspira Women'S Health INC | $68.84 | 2022 | |
| Coopersurgical, INC. | $65.84 | 2019-2025 | Paragard T 380a |
| Therapeuticsmd, INC. | $61.80 | 2020-2022 | |
| Amgen INC. | $61.29 | 2019-2024 | Evenity, Prolia |
| Convatec INC. | $46.36 | 2019-2022 | |
| Scynexis, INC. | $41.27 | 2022 | |
| Davol INC. | $38.34 | 2022 | |
| Dilon Technologies, INC. | $30.48 | 2024 | Hemoblast Bellows |
| Minerva Surgical, INC | $26.69 | 2020-2021 | |
| Inari Medical, INC. | $25.39 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Mycovia Pharmaceuticals, INC. | $24.69 | 2023 | Vivjoa |
| Roche Diagnostics Corporation | $20.33 | 2019 | |
| Agile Therapeutics, INC. | $20.16 | 2021 | |
| Becton, Dickinson and Company | $17.98 | 2024 | Bd Onclarity |
| Meditrina | $17.37 | 2025 | |
| Evofem Biosciences, INC. | $14.24 | 2021 | |
| Medtronic, INC. | $13.67 | 2024 | Interstim |
| Teva Pharmaceuticals USA, INC. | $12.75 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Champlin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.